JMVYX | VEVYX | JMVYX / VEVYX | |
Total Expense Ratio | 0.60 | 0.66 | 91% |
Annual Report Gross Expense Ratio | 0.69 | 0.66 | 105% |
Fund Existence | 9 years | 12 years | - |
Gain YTD | 2.260 | 1.702 | 133% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 15000000 | 1000000 | 1,500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.7B | 17.6B | 72% |
Annual Yield % from dividends | 1.04 | 1.09 | 95% |
Returns for 1 year | -2.44 | -6.88 | 35% |
Returns for 3 years | 6.26 | 9.92 | 63% |
Returns for 5 years | 20.04 | 42.60 | 47% |
Returns for 10 years | N/A | 48.88 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LRGC | 72.68 | 0.55 | +0.76% |
AB US Large Cap Strategic Equities ETF | |||
XTAP | 38.48 | 0.10 | +0.25% |
Innovator US Equity Acltd Pls ETF™ April | |||
LFAK | 133.71 | N/A | N/A |
LifeX 2052 Longevity Income ETF | |||
TOTL | 39.63 | -0.01 | -0.03% |
SPDR® DoubleLine® Total Return Tact ETF | |||
CURE | 74.62 | -2.63 | -3.40% |
Direxion Daily Healthcare Bull 3X ETF |